Lombard Odier Asset Management (USA) Corp - 31 Dec 2024 SCHEDULE 13G/A Report for Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares")

Filing Manager: Lombard Odier Asset Management (USA) Corp
Reporting Manager: Lombard Odier Asset Management (USA) Corp
Security: Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares")
Shares outstanding: 141M shares
Disclosed Ownership: 10.7M shares
Ownership: 7.6%
Form type: SCHEDULE 13G/A
Filing time: 11 Feb 2025, 18:41:36
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lombard Odier Asset Management (USA) Corp	7.6%	10.7M	0	10.7M	/s/ Elyse Strauss	Authorized Signatory